Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Caroline Van Vleck

Pediatrics Washington, DC Medical Doctor

NPI 1386775690 CMS profile 153115

4900 Massachusetts Ave., Nw, Lower Level, Washington, DC 20016

Open in the dashboard

General payments

$18,319

121 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Caroline Van Vleck of Washington, DC is reported in the CMS Open Payments database as having received $18,319 across 121 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $735 18
2024 General $16,105 31
2023 General $512 20
2022 General $341 17
2021 General $202 11
2020 General $138 8
2019 General $285 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Caroline Van Vleck
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Caroline Van Vleck were reported at $735. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Caroline Van Vleck Pediatrics median Middle half National median
2019 $285 $86 $31–$183 $163
2020 $138 $49 $22–$110 $114
2021 $202 $68 $27–$158 $132
2022 $341 $77 $30–$173 $149
2023 $512 $88 $33–$190 $160
2024 $16,105 $94 $34–$206 $164
2025 $735 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Sanofi-Aventis U.S. LLC $16,081 19 payments
  2. Merck Sharp & Dohme Corporation $367 18 payments
  3. Pfizer Inc. $365 17 payments
  4. Cranial Technologies, Inc $293 21 payments
  5. Sanofi US Services Inc. $286 1 payment
  6. kaleo, Inc. $257 11 payments
  7. Sanofi Pasteur Inc. $101 5 payments
  8. Genentech USA, Inc. $81 4 payments
  9. Adlon Therapeutics L.P. $65 4 payments
  10. ARS Pharmaceuticals Operations, Inc. $57 2 payments
  11. Other $366 19 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $13,090 3 payments
  2. Food and Beverage $3,071 111 payments
  3. Travel and Lodging $2,157 7 payments
Products named General payments · program years 2019–2025
  1. TOUJEO $7,930 5 payments
  2. TZIELD $6,599 12 payments
  3. Doc Band $293 21 payments
  4. GARDASIL 9 $289 14 payments
  5. TRUMENBA $264 13 payments
  6. VAXELIS $234 11 payments
  7. AUVI-Q $199 9 payments
  8. COMIRNATY $192 9 payments
  9. VAXNEUVANCE $180 8 payments
  10. PREVNAR 20 $138 7 payments
  11. Other $1,538 76 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

121 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in District of Columbia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record